Literature DB >> 3760563

Monoclonal antibodies raised against denatured HLA-B locus heavy chains permit biochemical characterization of certain HLA-C locus products.

N J Stam, H Spits, H L Ploegh.   

Abstract

Twelve monoclonal antibodies (HC-MoAb) were prepared against a mixture of denatured HLA-B7 and -B40 heavy chains and were characterized by biochemical methods. The patterns of reactivity of 11 out of 12 of these MoAb were very similar and showed marked preference for the HLA-B locus heavy chains. A single antibody, HC-3, reacted with a subset of the HLA class I heavy chains recognized by the other HC-MoAb, which react with all HLA-B locus heavy chains tested. In pulse-chase experiments, only biosynthetic intermediates consisting of free class I heavy chains were precipitated by the HC MoAb. In addition to free HLA-B and minor quantities of some HLA-A heavy chains, additional class I polypeptides were recognized by the HC-MoAb. A number of these additional class I polypeptides showed a striking correlation with HLA-C as determined serologically. None of these polypeptides could be clearly identified in immunoprecipitations prepared from continuously labeled cells with the MoAb W6/32, previously thought to recognize all HLA-A, B, and C specificities. These findings suggest that in human cells, HLA-C locus products may be associated only weakly with B2m, explaining some of the difficulties encountered in biochemical studies of HLA-C antigens.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3760563

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  194 in total

1.  Recycling MHC class I molecules and endosomal peptide loading.

Authors:  M Grommé; F G Uytdehaag; H Janssen; J Calafat; R S van Binnendijk; M J Kenter; A Tulp; D Verwoerd; J Neefjes
Journal:  Proc Natl Acad Sci U S A       Date:  1999-08-31       Impact factor: 11.205

2.  Soluble beta2-mu-associated and beta2-mu-free HLA class I heavy chain serum levels in interferon-alpha nonresponder chronic hepatitis C patients. Markers of immune activation, and response to antiviral retreatment.

Authors:  F Puppo; F Torre; P Contini; M Ghio; S Brenci; R Brizzolara; N Sinelli; N Campo; F Indiveri; A Picciotto
Journal:  J Clin Immunol       Date:  2000-11       Impact factor: 8.317

3.  Visualization of the ER-to-cytosol dislocation reaction of a type I membrane protein.

Authors:  Edda Fiebiger; Craig Story; Hidde L Ploegh; Domenico Tortorella
Journal:  EMBO J       Date:  2002-03-01       Impact factor: 11.598

4.  Quality control of transmembrane domain assembly in the tetraspanin CD82.

Authors:  K S Cannon; P Cresswell
Journal:  EMBO J       Date:  2001-05-15       Impact factor: 11.598

5.  The oxidoreductase ERp57 efficiently reduces partially folded in preference to fully folded MHC class I molecules.

Authors:  Antony N Antoniou; Stuart Ford; Magnus Alphey; Andrew Osborne; Tim Elliott; Simon J Powis
Journal:  EMBO J       Date:  2002-06-03       Impact factor: 11.598

6.  Ubiquitylation of MHC class I by the K3 viral protein signals internalization and TSG101-dependent degradation.

Authors:  Eric W Hewitt; Lidia Duncan; Dina Mufti; John Baker; Philip G Stevenson; Paul J Lehner
Journal:  EMBO J       Date:  2002-05-15       Impact factor: 11.598

7.  Immune Surveillance Plays a Role in Locally Aggressive Giant Cell Lesions of Bone.

Authors:  Ahmad Al-Sukaini; Francis J Hornicek; Zachary S Peacock; Leonard B Kaban; Soldano Ferrone; Joseph H Schwab
Journal:  Clin Orthop Relat Res       Date:  2017-07-19       Impact factor: 4.176

8.  Development of a high-throughput assay to measure the neutralization capability of anti-cytomegalovirus antibodies.

Authors:  Thomas J Gardner; Cynthia Bolovan-Fritts; Melissa W Teng; Veronika Redmann; Thomas A Kraus; Rhoda Sperling; Thomas Moran; William Britt; Leor S Weinberger; Domenico Tortorella
Journal:  Clin Vaccine Immunol       Date:  2013-02-06

9.  Multiple structural and epigenetic defects in the human leukocyte antigen class I antigen presentation pathway in a recurrent metastatic melanoma following immunotherapy.

Authors:  Chien-Chung Chang; Giuseppe Pirozzi; Shao-Hsuan Wen; I-Hsin Chung; Bau-Lin Chiu; Simona Errico; Monica Luongo; Maria Luisa Lombardi; Soldano Ferrone
Journal:  J Biol Chem       Date:  2015-09-17       Impact factor: 5.157

10.  Alteration of HLA-B27 peptide presentation after infection of transfected murine L cells by Shigella flexneri.

Authors:  F Boisgérault; J Mounier; V Tieng; M C Stolzenberg; I Khalil-Daher; M Schmid; P Sansonetti; D Charron; A Toubert
Journal:  Infect Immun       Date:  1998-09       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.